Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro

Table 6

TMPRSS2 assay data.

Sample	Concentration	RFU	% inhibition	IC50
Control	0	43233358	0.00
Metadichol (ng/mL)	1.56	41305150	4.46	96.65 ng/mL
	3.12	39329385	9.03
	6.25	36713767	15.08
	12.5	33778222	21.87
	25	30695684	29.00
	50	26087008	39.66
	100	16009312	62.97
Camostat mesylate (μg/mL)	0.78	37984828	12.14	26.46 μg/mL
	1.56	35235186	18.50
	3.125	31685728	26.71
	6.25	29234396	32.38
	12.5	23276839	46.16
	25	18931887	56.21
	50	8797988	79.65